Cantor Fitzgerald initiates coverage on Biodel (NASDAQ: BIOD) with a Buy rating and a $33 price target.

Analysts highlighted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE